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Table. Odds ratio for readmission based on patient
speciﬁc characteristics among individuals undergoing
open and endovascular procedures
OR 95% CI P
Endovascular procedures
Age 0.98 0.96-1.00 .069
Female Sex 1.48 0.89-2.45 .133
Length of Stay 1.01 0.96-1.05 .822
Smoking (yes) 0.73 0.41-1.32 .300
Dialysis (yes) 4.02 2.08-7.77 <.001
Hypertension (yes) 2.13 0.92-4.94 .077
Diabetes (yes) 0.78 0.44-1.38 .391
BM 0.97 0.93-1.01 .156
COPD (yes) 1.66 0.84-3.26 .144
Elective Surgery (yes) 0.30 0.15-0.61 .001
Open procedures
Age 1.01 0.99-1.03 .379
Female Sex 1.34 0.87-2.08 .182
Length of Stay 1.00 0.98-1.02 .945
Smoking (yes) 0.99 0.60-1.63 .954
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for the SA cohort (P < .0001). Signiﬁcant differences in
intraoperative vascular lesions were not identiﬁed. Cranial
nerve damage was observed in 17 patients: six transient
nerve palsies in the RC cohort, and 11 in the SA group.
There were three patients with postoperative transient
ischemic attacks in the SA cohort, with none observed in
the RC group. This translates into a rate of 21% of postop-
erative complications for the RC cohort and 34% in the SA
group (P <. 08)
Conclusions: The retrocarotid dissection technique is
a safe, viable option for the treatment of CBT. It is associ-
ated with a signiﬁcant decrease in surgical time and hospital
stay.
Author Disclosures: C. A. Hinojosa: Nothing to
disclose; A. E. Nuñez-Salgado: Nothing to disclose; V.
Orozco-Sevilla: Nothing to disclose; L. J. Ortiz-López:
Nothing to disclose.Dialysis (yes) 2.60 1.07-6.31 .035
Hypertension (yes) 1.40 0.73-2.67 .311
Diabetes (yes) 1.53 0.95-2.47 .079
BMI 0.98 0.95-1.02 .390
COPD (yes) 1.20 0.65-2.25 .560
Elective Surgery (yes) 0.64 0.39-1.05 .079PS138.
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Objectives: Patients undergoing vascular surgery have
a high rate of unplanned 30-day readmission. The costs
associated with readmission have not been described. The
objective of this study is to determine the excess cost due
to 30-day unplanned readmission for patients undergoing
vascular surgery.
Methods: The American College of Surgeons Na-
tional Surgical Quality Improvement Program (ACS-
NSQIP) database was used to identify patients undergoing
vascular surgery at a single institution from January 2011
through June 2012. Costs for each patient’s index hospital-
ization, as well as all unplanned 30-day readmissions were
obtained using SAP BusinessObjects. Logistic regression
analyses were performed to determine associations between
patient characteristics and readmission, and t-tests were
performed for cost comparison.
Results: During the study period, 689 endovascular
and 648 open procedures were performed. The mean cost
of care for patients who required readmission after endovas-
cular procedures was $48,131 compared with $18,803 for
those not requiring readmission (P < .0001). The mean
cost of care for patients who required readmission after
open surgery was $49,605 compared with $27,820 for
those not requiring readmission (P < .0001). Refer to the
Table for results of logistic regression.
Conclusions: Here we have shown that 30-day un-
planned readmission after vascular surgery is associated
with a signiﬁcant increase in cost. The mean cost of care
for endovascular patients requiring readmission is >2.5-
times greater than those who do not. Similarly, the mean
cost of care for patients readmitted following open proce-
dures is >1.75-times greater than those who are not.Author Disclosures: T. Easterday: Nothing to disclose;
A. S. Gracon: Nothing to disclose; G. Lemmon: Nothing
to disclose; R. Motaganahalli: Nothing to disclose; J.
Slaven: Nothing to disclose; D. J. Weber: Nothing to
disclose.PS140.
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Objectives: We analyzed trends in endovascular aneu-
rysm repair (EVAR) length of stay (LOS) at a tertiary aca-
demic institution over the last decade.
Methods: Infrarenal EVARs from 2001 to 2013
were divided into three groups: 2001 to 2004: per-
formed as part of clinical trials; 2005 to 2008: multiple
devices were Food and Drug Administration-approved;
2009 to 2013: complex EVARs referred to academic
institutions. Trends in LOS and correlation with
severity of illness (SOI) based on All Patient Reﬁned
Diagnosis Related Groups (APR-DRG), and admis-
sion/disposition status were analyzed. LOS index was
compared with University Health Consortium (UHC)
Hospitals over the past 3 years.
Results: A total of 1265 EVARs were performed:
325 in group 1, 547 in group 2, and 393 in group 3.
Average LOS was 5.5 vs 4.9 vs 6 days (P < .01). While
moderate SOI was constant over time (P ¼ .66), preva-
lence of major/extreme SOI was greater in group 1,
reduced in group 2, and again increased in group 3 (P
< .01; Fig). The complication rate paralleled this pattern
(15.2% vs 8.6% vs 10.4%; P ¼ .02). The percentage of
patients discharged to a nursing home was 5.7% vs
8.2% vs 11.5% (P ¼ .03). Cases performed emergently
